Begin typing your search...
You Searched For "Suven Pharmaceuticals"
Advent Intl’s $2-bn Cohance Platform HQ to be in Hyd
Invests Rs 9,589 cr to acquire a controlling stake in Suven Pharmaceuticals and to also establish a 50,000-sft R&D lab in Genome Valley